Dattola A, Bernardini N, Campione E, et al. Evaluating the Efficacy of Bimekizumab Across Different Sensitive Areas in Moderate-to-Severe Psoriasis: 52-week Multicentric Real-Life Experience in Lazio, Italy. Dermatol Pract Concept. 2025;15(2):4976 . doi:10.5826/dpc.1502a4976